Effects of retinoic acid, 1,25-dihydroxyvitamin D3, cytosine arabinoside and α-interferon on bone marrow cells from patients with myelodysplastic syndromes
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 13 (12) , 1113-1121
- https://doi.org/10.1016/0145-2126(89)90157-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Therapeutic effects of low‐dose cytosine arabinoside, alpha‐interferon, 1α‐hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromesEuropean Journal of Haematology, 1988
- ACUTE MYELOGENOUS LEUKEMIA OF UNFAVOURABLE PROGNOSIS TREATED WITH RETINOIC ACID, VITAMIN D3, ALPHA‐INTERFERON AND LOW DOSES OF CYTOSINE ARA‐BINOSIDEScandinavian Journal of Haematology, 1986
- Recombinant human interferon sensitizes resistant myeloid leukemic cells to induction of terminal differentiationBiochemical and Biophysical Research Communications, 1985
- The effect of retinoids on CFU‐GM from normal subjects and patients with myelodysplastic syndromeBritish Journal of Haematology, 1985
- The role of interferon-γ in induction of differentiation of human myeloid leukemia cell lines, ML-1 and HL-60Biochemical and Biophysical Research Communications, 1984
- Is the Maturation Arrest in Myeloid Leukemia Reversible?Acta Medica Scandinavica, 1983
- Control of growth and normal differentiation in leukemic cells: Regulation of the developmental program and restoration of the normal phenotype in myeloid leukemiaJournal of Cellular Physiology, 1982
- Stimulation by interferon of induction of differentiation of human promyelocytic leukemia cellsBiochemical and Biophysical Research Communications, 1982
- NITROBLUE-TETRAZOLIUM TESTSThe Lancet, 1974
- Human bone marrow colony growth in agar‐gelJournal of Cellular Physiology, 1970